ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Bacterial Physiology Phage injection establishes CRISPR immunity – Nature.com

Continue reading

2017-04-10 Michael Zand NEWS

Bacterial Physiology Phage injection establishes CRISPR immunity – Nature.com

Bacterial Physiology Phage injection establishes CRISPR immunity
Nature.com
The CRISPR–Cas system protects bacteria from invaders by acquiring short DNA sequences from infecting viruses. These sequences (spacers) protect against subsequent infection by mediating the cleavage of invading DNA by Cas nuclease. The details of …

Continue reading

2017-04-10 Michael Zand NEWS

Stem cell drug screen yields potential alternative to statins – Science Daily

Science DailyStem cell drug screen yields potential alternative to statinsScience DailyNext, they generated induced pluripotent stem cells from these skin cells. Stem cells continually double their numbers while in culture. This meant that a sample of … Continue reading

2017-04-09 Michael Zand NEWS

Pioneering work on stem-cell therapies at UW deserves state support – Seattle Times

Bacterial Physiology Phage injection establishes CRISPR immunity
Nature.com
The CRISPR–Cas system protects bacteria from invaders by acquiring short DNA sequences from infecting viruses. These sequences (spacers) protect against subsequent infection by mediating the cleavage of invading DNA by Cas nuclease. The details of …

Continue reading

2017-04-09 Michael Zand NEWS

Stem cells may provide lasting treatment for HF – Healio


Seattle Times

Pioneering work on stem–cell therapies at UW deserves state support
Seattle Times
With stem–cell biology, we are ready to rebuild solid tissues like the heart and potentially cure our nation’s greatest cause of death and health-care expense. Clinical success will make Washington a destination for heart repair and other regenerative …

Continue reading

2017-04-09 Michael Zand NEWS

Synthetic Biology Market Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024 – Medgadget (blog)

Synthetic Biology Market Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024Medgadget (blog)Synthetic biology is a combination of biology and biomedical engineering principles that favors designing and construction of novel biological parts … Continue reading

2017-04-09 Michael Zand NEWS

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma – Healio

Stem cells may provide lasting treatment for HF
Healio
The researchers made patches out of stem cells from thigh muscles of the participants. The patches were then surgically glued on to the surface of the participants’ hearts. For patients with ischemic cardiomyopathy, improvements were seen from baseline …

Continue reading

2017-04-09 Michael Zand NEWS

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma – Healio

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma
Healio
NEW YORK — Mario Sznol, MD, professor of medicine at Yale Cancer Center, discusses whether single-agent or combination immunotherapy should be used to treat patients with melanoma at HemOnc Today Melanoma and Cutaneous Malignancies.

Continue reading

2017-04-09 Michael Zand NEWS
  • 1
  • …
  • 1,867
  • 1,868
  • 1,869
  • 1,870
  • 1,871
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

VIDEO: Speaker compares single-agent vs. combination immunotherapy for melanoma
Healio
NEW YORK — Mario Sznol, MD, professor of medicine at Yale Cancer Center, discusses whether single-agent or combination immunotherapy should be used to treat patients with melanoma at HemOnc Today Melanoma and Cutaneous Malignancies.